Due to a scheduling conflict with Dr. Fauci’s calendar, this event was rescheduled. Tune in at 3:30pm on Feb. 18 for the rescheduled event. – ed.
William & Mary President Katherine A. Rowe will host a virtual community conversation with Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci on Jan. 26 at 3 p.m.
The topics for the discussion will include the science driving decision making around COVID-19, lessons learned, vaccinations and other pressing matters related to the pandemic. W&M Student Assembly President Anthony “AJ” Joseph ’21 will ask questions on behalf of the campus community during the livestreamed event. No registration is required.
“We launch the spring semester during a moment of deep uncertainty about the national public health picture in the coming months,” Rowe said in a message to the campus community announcing the virtual event and steps the university is taking to safeguard health this coming semester. “We hope to address the most pressing interests of this community in that conversation.”
Rowe launched the community conversation series last March to address questions about how the university is responding to the COVID-19 pandemic. Since then, the series has featured faculty, staff, students and alumni discussing the ways in which the pandemic has transformed their lives – with topics ranging from managing mental health and wellness to deep data dives into the science behind the university’s decisions.
Fauci is the first guest from outside the W&M community to appear in the series and will be volunteering his time at no cost. He was appointed director of NIAID in 1984 and has advised six presidents on domestic and global health issues. He will continue to serve in that role in the new administration of President-elect Joe Biden.
According to his NIAID biography, Dr. Fauci oversees an extensive portfolio of basic and applied research to prevent, diagnose and treat emerging diseases such as COVID-19, as well as established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis and malaria.